N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)

C75H97N19O7S — CID 167628495

IUPACN-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)
SMILESCCS(=O)(=O)NC1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)C1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCC(C)(O)CC4)c3)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCC(C)(O)CC4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C25H33N7O3S.2C25H32N6O2/c1-4-36(33,34)30-19-5-6-20(11-19)32-15-21(12-28-32)35-25-24(26)27-13-23(29-25)17-9-16(2)22-7-8-31(3)14-18(22)10-17;2*1-16-10-17(11-18-14-30(3)9-6-21(16)18)22-13-27-23(26)24(29-22)33-20-12-28-31(15-20)19-4-7-25(2,32)8-5-19/h9-10,12-13,15,19-20,30H,4-8,11,14H2,1-3H3,(H2,26,27);2*10-13,15,19,32H,4-9,14H2,1-3H3,(H2,26,27)
InChIKeyNLIPTMOQIVNERC-UHFFFAOYSA-N
MW1408.79 g/mol
LogP10.80
Rot. Bonds15

About N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)

N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol) (PubChem CID 167628495) has the molecular formula C75H97N19O7S and a molecular weight of 1408.79 g/mol. Its IUPAC name is N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol).

Molecular Properties

Compound NameN-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)
PubChem CID167628495
Molecular FormulaC75H97N19O7S
Molecular Weight1408.79 g/mol
Exact Mass1407.75
IUPAC NameN-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)
SMILESCCS(=O)(=O)NC1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)C1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCC(C)(O)CC4)c3)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCC(C)(O)CC4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C25H33N7O3S.2C25H32N6O2/c1-4-36(33,34)30-19-5-6-20(11-19)32-15-21(12-28-32)35-25-24(26)27-13-23(29-25)17-9-16(2)22-7-8-31(3)14-18(22)10-17;2*1-16-10-17(11-18-14-30(3)9-6-21(16)18)22-13-27-23(26)24(29-22)33-20-12-28-31(15-20)19-4-7-25(2,32)8-5-19/h9-10,12-13,15,19-20,30H,4-8,11,14H2,1-3H3,(H2,26,27);2*10-13,15,19,32H,4-9,14H2,1-3H3,(H2,26,27)
InChIKeyNLIPTMOQIVNERC-UHFFFAOYSA-N
XLogP10.80
TPSA332.90 Ų
H-Bond Donors6
H-Bond Acceptors25
Rotatable Bonds15
Heavy Atoms102
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001408.79
LogP ≤ 510.80
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1025

Analyze N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)?
The IUPAC name of N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol) (CID 167628495) is N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol).
What is the SMILES notation for N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)?
The canonical SMILES for N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol) is CCS(=O)(=O)NC1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)C1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCC(C)(O)CC4)c3)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCC(C)(O)CC4)c3)n2)cc2c1CCN(C)C2.
What is the InChIKey of N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)?
The InChIKey is NLIPTMOQIVNERC-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H33N7O3S.2C25H32N6O2/c1-4-36(33,34)30-19-5-6-20(11-19)32-15-21(12-28-32)35-25-24(26)27-13-23(29-25)17-9-16(2)22-7-8-31(3)14-18(22)10-17;2*1-16-10-17(11-18-14-30(3)9-6-21(16)18)22-13-27-23(26)24(29-22)33-20-12-28-31(15-20)19-4-7-25(2,32)8-5-19/h9-10,12-13,15,19-20,30H,4-8,11,14H2,1-3H3,(H2,26,27);2*10-13,15,19,32H,4-9,14H2,1-3H3,(H2,26,27).
What are the key properties of N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol)?
N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol) has a molecular weight of 1408.79 g/mol, XLogP of 10.80, 15 rotatable bonds, 6 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]cyclopentyl]ethanesulfonamide;bis(4-[4-[3-amino-6-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)pyrazin-2-yl]oxypyrazol-1-yl]-1-methylcyclohexan-1-ol) is sourced from PubChem (CID 167628495), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).